Evidence map›Paper›PMID 33866379›Full record

ArticleCalcified tissue international2021

Correction to: A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM).

E Cavalier, R Eastell, N R Jørgensen, K Makris, S Tournis, S Vasikaran, J A Kanis, C Cooper, H Pottel, H A Morris and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Calcified tissue international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

E CavalierDepartment of Clinical Chemistry, University of Liège, CHU Sart-Tilman, Domaine du Sart-Tilman, B-4000, Liège, Belgium. Etienne.cavalier@chu.ulg.ac.be.
R EastellMellanby Centre for Bone Research, University of Sheffield, Sheffield, UK.
N R JørgensenDepartment of Clinical Biochemistry, Rigshospitalet, 2600, Glostrup, Denmark.
K MakrisClinical Biochemistry Department, KAT General Hospital, 14561, Athens, Greece.
S TournisLaboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, University of Athens, 14561, Athens, Greece.
S VasikaranPathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, WA, 6150, Australia.
J A KanisCentre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK.
C CooperThe MRC Epidemiology Resource Centre, Southampton General Hospital, University of Southampton, Southampton, SO16 6YD, UK.
H PottelDepartment of Public Health and Primary Care, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
H A MorrisSchool of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, 5000, Australia.
IFCC-IOF Committee for Bone Metabolism (C-BM)

Funding

Medical Research Council MC_PC_21000
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33866379
PMCPMC8166697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.